A new drug to treat advanced lung cancer has been approved by the U.S. Food and Drug Administration.
Gilotrif (afatinib) is approved to treat patients with a specific subtype of of non-small cell lung cancer (NSCLC). About 85 percent of lung cancers are NSCLC, making it the most common type of lung cancer.
Gilotrif is approved to treat tumors that carry key deletions on the epidermal...
Content Preview This content is exclusive for Newsday digital access and 7-day home delivery subscribers and Optimum Online customers.
Source: http://www.newsday.com/news/health/fda-approves-new-drug-for-advanced-lung-cancer-1.5675185
ncaa bracket bracket Jason Terry Steubenville rape Beyonce Bow Down Jason Molina UCF
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.